MONTREAL, March 26, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a pan-American (ex-US) specialty pharmaceutical company, announced today the launch of Minjuvi ® ...
Positive azenosertib clinical data demonstrated clinically meaningful results in patients with Cyclin E1+ platinum-resistant ovarian cancer ...
Building on a three-decade reputation for helping consumers with a wide breadth of health conditions, Humanset has officially launched as a transformational product that optimizes the settings of the ...
OMNIVISION, a leading global developer of semiconductor technology, including advanced digital imaging, analog, and display solutions, and Biotech Dental, a specialist in the design and manufacture of ...
NASDAQ BPMC opened at $88.72 on Thursday. Blueprint Medicines has a fifty-two week low of $80.68 and a fifty-two week high of $121.90. The stock’s 50-day moving average is $99.47 and its two ...
We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...
BPMC opened at $88.72 on Friday. Blueprint Medicines has a fifty-two week low of $80.68 and a fifty-two week high of $121.90. The business has a 50-day moving average of $99.47 and a 200-day ...
In this article, we are going to look at where Blueprint Medicines Corporation (NASDAQ:BPMC) stands against other biotech stocks. The biotechnology sector is gaining new momentum with better ...
In this article, we are going to take a look at where Blueprint Medicines Corporation (NASDAQ:BPMC) stands against other stocks Insiders are selling in March. Wall Street experienced a challenging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback